Invesco Biotechnology & Genome ETF (PBE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PBE | VHT | XBI | ||
| Company | Invesco Biotechnology & Genome ETF | Healthcare ETF Vanguard | S&P Biotech SPDR | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE Arca | NYSE Arca | ||
| Open | 81.53 | 275.77 | 137.77 | ||
| High | 81.92 | 279.09 | 139.19 | ||
| Low | 81.53 | 275.77 | 137.21 | ||
| Latest | 81.87 | 278.45 | 138.67 | ||
| Change | +1.17 | +4.16 | +3.21 | ||
| % Change | +1.45% | +1.52% | +2.37% | ||
| Volume | 3,500 | 142,800 | 10,212,601 | ||
| 20-Day Average Volume | 6,460 | 180,455 | 10,296,940 | ||
| Previous Close | 80.70 | 274.29 | 135.46 | ||
| Industry | N/A | N/A | Finance - Investment Funds | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 78.84 | 272.89 | 128.04 | ||
| 20-Day Raw Stochastic | 99.35% | 94.53% | 97.52% | ||
| 20-Day Relative Strength | 57.26 | 50.69 | 64.91 | ||
| Weighted Alpha | +31.48 | +9.75 | +74.92 | ||
| Today's Opinion | 56% Buy | 8% Sell | 100% Buy | ||
| Previous Opinion | 40% Buy | 8% Sell | 100% Buy | ||
| Last Month's Opinion | 8% Sell | 8% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.85% since 04/10/26 | +1.71% since 04/10/26 | +7.13% since 04/10/26 | ||
| Low | 78.65 on 04/13/26 | 272.49 on 04/13/26 | 130.19 on 04/13/26 | ||
| High | 81.92 on 04/17/26 | 279.23 on 04/14/26 | 139.19 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | +5.12% since 03/17/26 | +0.48% since 03/17/26 | +11.66% since 03/17/26 | ||
| Low | 75.50 on 03/27/26 | 264.97 on 03/27/26 | 118.19 on 03/24/26 | ||
| High | 81.92 on 04/17/26 | 279.23 on 04/14/26 | 139.19 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +1.19% since 01/16/26 | -3.89% since 01/16/26 | +11.67% since 01/16/26 | ||
| Low | 75.50 on 03/27/26 | 264.97 on 03/27/26 | 118.19 on 03/24/26 | ||
| High | 84.65 on 01/22/26 | 296.59 on 01/22/26 | 139.19 on 04/17/26 | ||
| 6-Month | |||||
| %Chg | +13.36% since 10/17/25 | +4.09% since 10/17/25 | +28.64% since 10/17/25 | ||
| Low | 72.27 on 10/30/25 | 264.97 on 03/27/26 | 106.30 on 11/07/25 | ||
| High | 85.73 on 01/07/26 | 298.61 on 01/07/26 | 139.19 on 04/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 254,630 | 16,562,206 | 9,152,220 | ||
| Shares Outstanding, K | 3,110 | 59,480 | 66,000 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 0 | 0 | 0 | ||
| Last Quarter Sales | N/A | N/A | N/A | ||
| Last Quarter Net Income | N/A | N/A | N/A | ||
| 60-Month Beta | 0.76 | 0.67 | 0.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | 0.082 on 03/23/26 | 0.994 on 03/24/26 | 0.407 on 12/22/25 | ||
| Next Ex-Dividends Date | 03/23/26 | 03/24/26 | 12/22/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 19.29 | 27.80 | 18.21 | ||